Healthcare · Industry
Biotechnology - List & Prices (608 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Evaxion A/S | EVAX | $3.71 | $33.47M | — | |
| Quince Therapeutics, Inc. | QNCX | $40.27 Oct 20, 2026 | $32.27M | — | |
| Filana Therapeutics, Inc. | FLNA | $0.66 | $31.85M | — | |
| Metagenomi Therapeutics, Inc. | MGX | $0.83 | $31.31M | — | |
| Aligos Therapeutics, Inc. | ALGS | $4.96 | $30.97M | — | |
| CEL-SCI Corporation | CVM | $1.62 | $28.49M | — | |
| TransCode Therapeutics, Inc. | RNAZ | $1.66 | $28.11M | — | |
| Resverlogix Corp. | RVX.TO | CA$0.08 | CA$27.54M | — | |
| ABVC BioPharma, Inc. | ABVC | $1.00 | $26.69M | — | |
| Atossa Therapeutics, Inc. | ATOS | $2.53 | $25.25M | — | |
| IGC Pharma, Inc. | IGC | $0.24 | $25.07M | — | |
| BeyondSpring Inc. | BYSI | $0.50 | $24.95M | — | |
| NextCure, Inc. | NXTC | $5.42 | $24.79M | — | |
| Immutep Limited | IMMP | $3.28 | $24.17M | — | |
| Estrella Immunopharma, Inc. | ESLA | $0.55 | $23.92M | — | |
| Seres Therapeutics, Inc. | MCRB | $2.30 | $23.10M | — | |
| Context Therapeutics Inc. | CNTX | $0.23 | $22.40M | — | |
| Polyrizon Ltd. | PLRZ | $9.20 | $22.34M | — | |
| Kyntra Bio, Inc. | KYNB | $5.21 | $21.10M | — | |
| Akari Therapeutics, Plc | AKTX | $8.76 | $20.02M | — | — |
| Quoin Pharmaceuticals, Ltd. | QNRX | $3.99 | $19.17M | — | |
| Marker Therapeutics, Inc. | MRKR | $1.13 | $18.84M | — | |
| Neuphoria Therapeutics Inc. | NEUP | $3.48 | $18.83M | — | |
| Cocrystal Pharma, Inc. | COCP | $0.94 | $18.18M | — | |
| NewcelX Ltd. | NCEL | $2.95 | $17.04M | — | — |
| aTyr Pharma, Inc. | ATYR | $0.17 | $16.90M | — | |
| Jasper Therapeutics, Inc. | JSPR | $0.50 | $16.78M | — | |
| SeaStar Medical Holding Corporation | ICU | $3.17 | $16.68M | — | |
| Pasithea Therapeutics Corp. | KTTA | $0.49 | $16.30M | — | |
| Dyadic International, Inc. | DYAI | $0.40 | $16.03M | — | |
| BioCardia, Inc. | BCDA | $0.98 | $15.74M | — | |
| Quantum BioPharma Ltd. | QNTM | $2.40 | $15.43M | — | |
| Fractyl Health, Inc. | GUTS | $1.15 | $15.25M | — | |
| TScan Therapeutics, Inc. | TCRX | $0.22 | $15.18M | — | |
| Radiopharm Theranostics Limited | RADX | $0.98 | $14.28M | — | |
| Allarity Therapeutics, Inc. | ALLR | $0.88 | $14.00M | — | |
| Tvardi Therapeutics, Inc. | TVRD | $1.02 | $13.61M | — | |
| Daré Bioscience, Inc. | DARE | $0.69 | $13.53M | — | |
| Actuate Therapeutics, Inc. Common stock | ACTU | $0.56 | $13.50M | — | |
| Pluri Inc. | PLUR | $1.05 | $13.24M | — | |
| Lipocine Inc. | LPCN | $1.60 | $13.19M | — | |
| Cellectar Biosciences, Inc. | CLRB | $1.28 | $13.14M | — | |
| Synlogic, Inc. | SYBX | $1.07 | $13.11M | — | |
| Vyome Holdings, Inc. | HIND | $1.84 | $12.91M | — | — |
| Cerenome, Inc. | CNSY | $1.73 | $12.75M | — | |
| Anebulo Pharmaceuticals, Inc. | ANEB | $0.30 Oct 20, 2026 | $12.03M | — | |
| AEON Biopharma, Inc. | AEON | $0.24 | $11.98M | — | |
| Passage Bio, Inc. | PASG | $3.59 | $11.55M | — | |
| Lisata Therapeutics, Inc. | LSTA | $1.05 | $11.34M | — | |
| GT Biopharma, Inc. | GTBP | $5.41 | $11.15M | — |
Evaxion A/S
Healthcare / Biotechnology
- Market Cap
- $33.47M
- P/E
- unprofitable
Quince Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $32.27M
- P/E
- unprofitable
Filana Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $31.85M
- P/E
- unprofitable
Metagenomi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $31.31M
- P/E
- unprofitable
Aligos Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $30.97M
- P/E
- unprofitable
CEL-SCI Corporation
Healthcare / Biotechnology
- Market Cap
- $28.49M
- P/E
- unprofitable
TransCode Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $28.11M
- P/E
- unprofitable
Resverlogix Corp.
Healthcare / Biotechnology
- Market Cap
- CA$27.54M
- P/E
- unprofitable
ABVC BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $26.69M
- P/E
- unprofitable
Atossa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.25M
- P/E
- unprofitable
IGC Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.07M
- P/E
- unprofitable
BeyondSpring Inc.
Healthcare / Biotechnology
- Market Cap
- $24.95M
- P/E
- unprofitable
NextCure, Inc.
Healthcare / Biotechnology
- Market Cap
- $24.79M
- P/E
- unprofitable
Immutep Limited
Healthcare / Biotechnology
- Market Cap
- $24.17M
- P/E
- unprofitable
Estrella Immunopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $23.92M
- P/E
- unprofitable
Seres Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $23.10M
- P/E
- unprofitable
Context Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $22.40M
- P/E
- unprofitable
Polyrizon Ltd.
Healthcare / Biotechnology
- Market Cap
- $22.34M
- P/E
- unprofitable
Kyntra Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $21.10M
- P/E
- unprofitable
Akari Therapeutics, Plc
Healthcare / Biotechnology
- Market Cap
- $20.02M
Quoin Pharmaceuticals, Ltd.
Healthcare / Biotechnology
- Market Cap
- $19.17M
- P/E
- unprofitable
Marker Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $18.84M
- P/E
- unprofitable
Neuphoria Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $18.83M
- P/E
- unprofitable
Cocrystal Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $18.18M
- P/E
- unprofitable
NewcelX Ltd.
Healthcare / Biotechnology
- Market Cap
- $17.04M
aTyr Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $16.90M
- P/E
- unprofitable
Jasper Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $16.78M
- P/E
- unprofitable
SeaStar Medical Holding Corporation
Healthcare / Biotechnology
- Market Cap
- $16.68M
- P/E
- unprofitable
Pasithea Therapeutics Corp.
Healthcare / Biotechnology
- Market Cap
- $16.30M
- P/E
- unprofitable
Dyadic International, Inc.
Healthcare / Biotechnology
- Market Cap
- $16.03M
- P/E
- unprofitable
BioCardia, Inc.
Healthcare / Biotechnology
- Market Cap
- $15.74M
- P/E
- unprofitable
Quantum BioPharma Ltd.
Healthcare / Biotechnology
- Market Cap
- $15.43M
- P/E
- unprofitable
Fractyl Health, Inc.
Healthcare / Biotechnology
- Market Cap
- $15.25M
- P/E
- unprofitable
TScan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $15.18M
- P/E
- unprofitable
Radiopharm Theranostics Limited
Healthcare / Biotechnology
- Market Cap
- $14.28M
- P/E
- unprofitable
Allarity Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.00M
- P/E
- unprofitable
Tvardi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.61M
- P/E
- unprofitable
Daré Bioscience, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.53M
- P/E
- unprofitable
Actuate Therapeutics, Inc. Common stock
Healthcare / Biotechnology
- Market Cap
- $13.50M
- P/E
- unprofitable
Pluri Inc.
Healthcare / Biotechnology
- Market Cap
- $13.24M
- P/E
- unprofitable
Lipocine Inc.
Healthcare / Biotechnology
- Market Cap
- $13.19M
- P/E
- unprofitable
Cellectar Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.14M
- P/E
- unprofitable
Synlogic, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.11M
- P/E
- unprofitable
Vyome Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $12.91M
Cerenome, Inc.
Healthcare / Biotechnology
- Market Cap
- $12.75M
- P/E
- unprofitable
Anebulo Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $12.03M
- P/E
- unprofitable
AEON Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $11.98M
- P/E
- unprofitable
Passage Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $11.55M
- P/E
- unprofitable
Lisata Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $11.34M
- P/E
- unprofitable
GT Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $11.15M
- P/E
- unprofitable
Showing 451–500 of 608 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.